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Routine pulse oximetry screening (POS) of newborn babies before discharge from hospital has been 
shown to identifying cases of CCHD with consistent test accuracy1 and to reduce mortality from 
these conditions by one-third.2
There is increasing uptake of POS in high and middle income countries;1-4 in July 2018, after several 
years of state-by-state introduction, POS became mandatory across the USA2 which means that 
almost 4 million babies a year will undergo the test in that country alone. 
POS reduces the ‘diagnostic gap’ for CCHD, i.e. it identifies additional cases which are missed by 
other screening methods such as antenatal ultrasound and postnatal examination.1  The size of this 
gap varies depending on local circumstances, but the addition of POS consistently reduces it to less 
than 10%.4
However, as described in this recent Archimedes article,5  POS is not a perfect test. Some babies 
(particularly those with defects that obstruct left ventricular outflow such as coarctation of the aorta 
[CoA] and interrupted aortic arch[IAA]) are missed by POS and other routine screening tests4 and 
Searle and colleagues quite rightly ask if an additional screening tool – perfusion index (PI) - could 
have identified such defects earlier.5
As Searle et al describe, PI is an assessment of pulse strength - m asured at the same time as oxygen 
saturations by a pulse oximeter which calculates the ratio of pulsatile to non-pulsatile blood. Lower 
PI values represent reduced perfusion.5
Given that critical obstruction of left ventricular outflow is highly likely to affect peripheral perfusion 
the suggestion that PI may be a useful adjunct to oxygen saturation screening (in order to increase 
detection of those CCHDs which are commonly missed) is not unreasonable.
Although the premise for considering the use of PI in this context is logical and appealing, this review 
demonstrates inherent concerns which mean that the case for considering PI as an additional 
screening test for CCHD is not yet proven.5
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Five studies, which investigated the role of PI in increasing detection of CCHD during routine POS - 
and including just over 1000 to over 42 000 babies screened - are described in detail.4 Three of the 
five were significantly underpowered, each reporting data from under 3 200 screened babies. The 
two larger studies reported around 10 000 and 42 000 screened babies.
Measuring PI in 10 000 healthy term newborns between 1 and 120 hours of age (median 42), 
Granelli et al established the normal range for this population; describing a median value of 1.68 
(pre-ductal) and 1.71 (post-ductal).5  The range was very wide (0.02-20.0), 5th centile was 0.7 and no 
age-specific differences between values at 1 hour and 5 days were identified. In a much smaller, 
retrospective study of 2768 babies, Jagatheesen et al confirmed similar values for PI in babies at 24 
hours of age.5
Using the 5th centile as a cut-off for an abnormal value, Granelli showed that five out of nine babies 
(56%) with a [previously diagnosed] CCHD obstructing left ventricular outflow could be identified 
using PI. POS alone diagnosed 6 out of 9 although 2 of the 3 missed by POS were identified by PI. 
Although providing useful data, this study has its limitations, particularly when considering the 
possibility of using PI as a screening test. The babies with the CCHD already had an established 
diagnosis and were therefore perhaps a biased group, also PI was measured after 36 hours of age in 
56% of those screened which limits the applicability of the data, particularly for POS screening 
algorithms which recommend screened around the first 24 hours of life. 
In a large prospective study from Italy, Schena et al measured PI (in addition to performing POS) in 
over 42 000 asymptomatic babies in whom CCHD was not suspected antenatally.5  Again, screening 
(using a higher PI cut-off value of 0.9) took place later (between 48 and 72 hours of age). 
Unfortunately, the prevalence of CCHD in the screened population was very low (76% of CCHD were 
diagnosed antenatally and 84% of the remainder were diagnosed before screening could take place. 
Only 7 babies with CCHD (out of a total cohort of 187) were screened and 4 were missed by both 
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POS and PI (including 2 CoAs and 1 IAA). PI picked up 1 CoA that was missed by POS and the 2 
remaining CCHDs were picked up by POS alone.5
Finally, two much smaller studies from India and Turkey are reported.5 Ramesh et al used PI (cut-off 
value of 0.7) in combination with POS in a cohort of just over 1 000 babies and identified one CCHD 
(which was also picked up both antenatally and using POS), but missed 2 further cases which were 
identified by POS. Uyger et al retrospectively applied PI to 3 175 babies screened by POS (including 
33 with an antenatal diagnosis of a heart defect) using a much higher cut off values of 1.1 for pre-
ductal and 1.2 for post-ductal measurements (the 5th centiles in this cohort). POS identified 25 out of 
33 CCHD (sensitivity 75.9%) whereas PI with the higher cut-off had a sensitivity for CCHD of 60.6% 
(post-ductal) and 63.6% (pre-ductal) – including 3 CCHD missed by POS. When the more widely 
accepted cut off of 0.7 was applied, the sensitivities for PI fell to 33.3% and 36.4% respectively. False 
positives were also very high – 2.7% (pre-ductal) and 3.6% (post-ductal).
So where does this leave us and how should we use these data? The available evidence suggests that 
normal PI values seem to be fairly stable and consistent over the first few days of life. What is less 
clear is the natural history of PI in CCHD particularly left h art obstruction. The rationale behind 
using PI as a potential screen for these conditions is that perfusion is compromised particularly as 
the ductus arteriosus closes. The timing of ductal closure is variable and as the number of missed 
cases highlighted in the review suggest, if the duct is still open in a left heart CCHD, the PI may not 
be abnormal. Of additional concern is the lack of acceptable ‘normal’ values for PI in this group and 
the unacceptably high false positives rates if values below the 5th centile are used as a screening cut-
off. 
And yet, these studies do show that PI alone will identify some babies with CCHD that would 
otherwise be missed by all other screening methods and so perhaps we should not discount this 
technique altogether. As was the case with the earlier studies examining POS,1 we need more data in 
order to identify more precisely the test accuracy of PI. As more babies worldwide are being 
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screened using POS, PI data could be collected alongside the saturation results and, if linked with 
outcome data, may provide the necessary information required. In addition, newer technologies 
may allow a more rigorous cotside assessment of perfusion and left heart function.
Until then, as Searle and colleagues rightly conclude, we do not have enough evidence yet to 
recommend adding PI to any newborn POS programme.
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